# Filing Detail

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0002094682-25-000001
Filing Date
2025-10-30
Accepted
2025-10-30 18:48:43
Documents
15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | primary_doc.html | SCHEDULE 13D |
1 |  | primary_doc.xml | SCHEDULE 13D | 32348
2 | JOINT FILING AGREEMENT | jfa.pdf | EX-1 | 117474
3 | POA BUTTERWORTH | butterworth.pdf | EX-2 | 53188
4 | POA R JONES | richjones2.pdf | EX-3 | 35291
5 | POA E JONES | ejones2.pdf | EX-4 | 84916
6 | POA DOWNING | downing3.pdf | EX-5 | 84118
7 | POA KOTEY | kotey4.pdf | EX-7 | 168030
8 | POA COLE | cole4.pdf | EX-8 | 165316
9 | POA CHAUDREY | chaudrey2.pdf | EX-9 | 175244
10 | POA BABB | babb2.pdf | EX-10 | 166274
11 | POA CRAIG | craig6.pdf | EX-11 | 172579
12 | POA NICHOLLS | nicholls3.pdf | EX-12 | 168352
13 | POA WARE | ware2.pdf | EX-13 | 84310
14 | POA HENNESSY | hennessy2.pdf | EX-17 | 167895
15 | POA DOUGLAS | douglas.pdf | EX-19 | 35449
| Complete submission text file | 0002094682-25-000001.txt |  | 2346748

Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-79364 | Film No.: 251437475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6 THE PENINSULA PANORAMA ROAD POOLE United Kingdom BH13 7RS
Business Address
Price Adrian (Filed by) CIK: 0002094682 (see all company filings)

Type: SCHEDULE 13D